These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 11807814

  • 1. Basic fibroblast growth factor modulates the expression of glycophorin A and c-kit and inhibits erythroid differentiation in K562 cells.
    Burger PE, Lukey PT, Coetzee S, Wilson EL.
    J Cell Physiol; 2002 Jan; 190(1):83-91. PubMed ID: 11807814
    [Abstract] [Full Text] [Related]

  • 2. Modification of expression of stem cell factor by various cytokines.
    Sugimoto Y, Koji T, Miyoshi S.
    J Cell Physiol; 1999 Nov; 181(2):285-94. PubMed ID: 10497307
    [Abstract] [Full Text] [Related]

  • 3. Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1/2 and deactivating p38 MAP kinase.
    Huang HM, Chang TW, Liu JC.
    Biochem Biophys Res Commun; 2004 Aug 06; 320(4):1247-52. PubMed ID: 15249224
    [Abstract] [Full Text] [Related]

  • 4. Mitogenic and anti-proliferative signals for neural crest cells and the neurogenic action of TGF-beta1.
    Zhang JM, Hoffmann R, Sieber-Blum M.
    Dev Dyn; 1997 Mar 06; 208(3):375-86. PubMed ID: 9056641
    [Abstract] [Full Text] [Related]

  • 5. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
    Yi ZC, Wang Z, Li HX, Liu MJ, Wu RC, Wang XH.
    Acta Pharmacol Sin; 2004 Feb 06; 25(2):231-8. PubMed ID: 14769215
    [Abstract] [Full Text] [Related]

  • 6. Basic fibroblast growth factor antagonizes transforming growth factor beta-mediated erythroid differentiation in K562 cells.
    Burger PE, Dowdle EB, Lukey PT, Wilson EL.
    Blood; 1994 Apr 01; 83(7):1808-12. PubMed ID: 8142649
    [Abstract] [Full Text] [Related]

  • 7. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW.
    Stem Cells; 2003 Apr 01; 21(5):557-67. PubMed ID: 12968110
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells.
    Ahdjoudj S, Kaabeche K, Holy X, Fromigué O, Modrowski D, Zérath E, Marie PJ.
    Exp Cell Res; 2005 Feb 01; 303(1):138-47. PubMed ID: 15572034
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. bFGF signaling and v-Myb cooperate in sustained growth of primitive erythroid progenitors.
    Bartůnek P, Pajer P, Karafiát V, Blendinger G, Dvorák M, Zenke M.
    Oncogene; 2002 Jan 17; 21(3):400-10. PubMed ID: 11821952
    [Abstract] [Full Text] [Related]

  • 13. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S, Bertolette D, Petrow-Sadowski C, Ruscetti FW.
    Platelets; 2007 Dec 17; 18(8):566-78. PubMed ID: 18041647
    [Abstract] [Full Text] [Related]

  • 14. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM, Khan MM, Wade FM, Wakade C, Mahesh VB, Brann DW.
    J Neurosci Res; 2007 Apr 17; 85(5):1033-45. PubMed ID: 17335076
    [Abstract] [Full Text] [Related]

  • 15. Neurokinin-A inhibits cell cycle activators in K562 cells and activates Smad 4 through a non-canonical pathway: a novel method in neural-hematopoietic axis.
    Ricardo M, Trzaska KA, Rameshwar P.
    J Neuroimmunol; 2008 Nov 15; 204(1-2):85-91. PubMed ID: 18760489
    [Abstract] [Full Text] [Related]

  • 16. [Basic fibroblast growth factor inhibits promoter activities of human alpha 1(I) procollagen gene induced by transforming growth factor-beta 1].
    Wan WD, Yang SL, Gao CF.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Nov 15; 16(6):401-3. PubMed ID: 12508433
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis.
    Spinello I, Quaranta MT, Pasquini L, Pelosi E, Petrucci E, Pagliuca A, Castelli G, Mariani G, Diverio D, Foà R, Testa U, Labbaye C.
    Oncogene; 2009 Jun 11; 28(23):2276-88. PubMed ID: 19421145
    [Abstract] [Full Text] [Related]

  • 20. Fibroblast growth factor-2 maintains the differentiation potential of nucleus pulposus cells in vitro: implications for cell-based transplantation therapy.
    Tsai TT, Guttapalli A, Oguz E, Chen LH, Vaccaro AR, Albert TJ, Shapiro IM, Risbud MV.
    Spine (Phila Pa 1976); 2007 Mar 01; 32(5):495-502. PubMed ID: 17334282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.